Consistent bone mineral density gains with intravenous ibandronate injections: Results from the DIVA study.

被引：0
|
作者：
Emkey, R
Halse, J
Kruse, HP
Hughes, C
Ward, P
Masanauskaite, D
Recker, RR
机构：
[1] Radiant Res, Wyomissing, PA USA
[2] Osteoporoseklin, Oslo, Norway
[3] Univ Hamburg, Klinikum Eppendorf, Hamburg, Germany
[4] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland
[5] Creighton Univ, Omaha, NE 68178 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2005年 / 20卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S285 / S285
页数：1
相关论文
共 50 条
  • [21] Favorable renal safety profile of intravenous ibandronate injections in postmenopausal osteoporosis: 1-year results from DIVA
    Delmas, P
    Reid, D
    Felsenberg, D
    Leigh, C
    Ward, P
    Sedarati, F
    Christiansen, C
    BONE, 2005, 36 : S419 - S420
  • [22] Renal tolerability profile of intravenous ibandronate injection in postmenopausal women with osteoporosis: Findings from the DIVA study.
    Emkey, R
    Olszynski, WP
    Bianchi, G
    Leigh, C
    Masanauskaite, D
    Sedarati, F
    Sambrook, P
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S295 - S296
  • [23] Intravenous ibandronate injections are at least as effective and similarly well tolerated as daily oral ibandronate in postmenopausal osteoporosis: 1-year results from DIVA
    Adami, S
    Nuti, R
    Czerwinski, E
    Hughes, C
    Ward, P
    Bonvoisin, B
    Tanko, LB
    BONE, 2005, 36 : S137 - S138
  • [24] Progressive efficacy improvements with quarterly intravenous ibandronate injections: The DIVA study long term extension
    Czerwinski, E.
    Langdahl, B.
    Stepan, J.
    Grant, R.
    Neate, C.
    Bianchi, G.
    CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S121 - S121
  • [25] Intermittent ibandronate injections in postmenopausal osteoporosis: Rationale and design of the dosing intravenous administration (DIVA) study
    Adami, S
    Recker, RR
    Reid, DM
    Kelly, S
    Jonkanski, I
    Gilbride, J
    Bonvoisin, B
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S56 - S56
  • [26] Low incidence of flu-like illness with intravenous ibandronate injections: DIVA 2-year results
    Bianchi, G.
    Sambrook, P. N.
    Lewiecki, E. M.
    Leigh, C.
    Mairon, N.
    Burdeska, A.
    Delmass, P. D.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 413 - 413
  • [27] Effect of oral ibandronate on hip structure: Results from the BONE study.
    Fuerst, T.
    Beck, T. J.
    Gaither, K.
    Kothari, M.
    Genant, H. K.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S287 - S287
  • [28] Favourable renal safety and tolerability profile of intravenous ibandronate injections in women with postmenopausal osteoporosis: 1-year results from diva
    Reid, DM
    Felsenberg, D
    Christiansen, C
    Leigh, C
    Ward, P
    Sedarati, F
    Delmas, PD
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 365 - 365
  • [29] Efficacy of intravenous ibandronate injections in postmenopausal osteoporosis: 1-year findings from DIVA.
    Bolognese, M
    Reid, DM
    Langdahl, B
    Hughes, C
    Ward, P
    Masanauskaite, D
    Olszynski, WP
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S96 - S96
  • [30] Incidence of influenza-like illness in women treated with intermittent intravenous ibandronate injections:: 1-year results from diva
    Delmas, PD
    Adami, S
    Felsenberg, D
    Tankó, LB
    Leigh, C
    Ward, P
    Masanauskaite, D
    Reid, DM
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 366 - +
12345